Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.

Quotes for Double Bond Pharmaceutical International AB

Right Now

+/-
0.174
%
11,28%
Latest
1.716
High
1.824
Low
1.504
Volume
69 682
Turnover (SEK)
118 235
Value (MSEK)
88,3

Board

CEO

  • Igor Lokot

Chairman Of The Board

  • Per Stålhandske

Board

  • Igor Lokot
  • Lars Thomander
  • Sergey Yanitsky

Videos